Literature DB >> 27793888

Regulation of the Expression of Cytoplasmic Polyadenylation Element Binding Proteins for the Treatment of Cancer.

Yun Chen1,2, Ya-Hui Tsai1,2, Sheng-Hong Tseng3.   

Abstract

Regulated mRNA translation plays an important role in normal cellular functions and cytoplasmic polyadenylation element binding proteins (CPEBs) are the key factors that control the elongation of poly(A) tail during translation. The expression of various CPEBs has been noted to be linked to tumorigenesis, tumor growth, invasiveness and angiogenesis; however, different CPEBs appear to play diverse roles in cancer. The evidence from the literature suggests that CPEB1 and CPEB3 act more likely as tumor suppressors; in contrast, CPEB2 and CPEB4 mainly exert oncogenic effects. In addition, different CPEB subtypes may interact with each other to regulate tumorigenesis. All four CPEB mRNAs contain multiple microRNA (miRNA) binding sites, while the functions of CPEBs are regulated by various miRNAs. These results indicate that CPEBs play a significant role in tumorigenesis; therefore, manipulation of the expression of different subtypes of CPEBs might modulate the behavior of cancer cells and provide new therapeutic concepts for cancer therapy. However, more studies are required to clarify their definite role in tumor development. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  CPEB; cancer; microRNA; review; tumorigenesis

Mesh:

Substances:

Year:  2016        PMID: 27793888     DOI: 10.21873/anticanres.11150

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  Micro RNAs Promoting Growth and Metastasis in Preclinical In Vivo Models of Subcutaneous Melanoma.

Authors:  Ulrich H Weidle; Simon AuslÄnder; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

Review 2.  New addiction to the NRF2-related factor NRF3 in cancer cells: Ubiquitin-independent proteolysis through the 20S proteasome.

Authors:  Akira Kobayashi; Tsuyoshi Waku
Journal:  Cancer Sci       Date:  2019-12-14       Impact factor: 6.716

3.  CPEB4 Inhibit Cell Proliferation via Upregulating p21 mRNA Stability in Renal Cell Carcinoma.

Authors:  Jiehui Di; Hui Wang; Zhongjun Zhao; Guang Zhao; Xiaobing Qin; Zhengxiang Han; Yong Liu
Journal:  Front Cell Dev Biol       Date:  2021-12-16

Review 4.  Translational Control in Liver Disease.

Authors:  Alexandra Balvey; Mercedes Fernandez
Journal:  Front Physiol       Date:  2021-11-29       Impact factor: 4.566

Review 5.  RBM24 in the Post-Transcriptional Regulation of Cancer Progression: Anti-Tumor or Pro-Tumor Activity?

Authors:  De-Li Shi
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639

6.  CPEB3-mediated MTDH mRNA translational suppression restrains hepatocellular carcinoma progression.

Authors:  He Zhang; Chendan Zou; Zini Qiu; Fang E; Qiang Li; Miao Chen; Dayong Wang; Qinrui Tan; Wanli Yin; Cedric Matunda; Hefei Wang; Yongjian Zhang; Chao Zhan; Chuxuan Wang; Yue Wu; Xiuchen Xuan; Yayan Wang; Chaoxia Zou; Guixiang Lv; Xu Gao
Journal:  Cell Death Dis       Date:  2020-09-23       Impact factor: 8.469

7.  CPEB4 promotes growth and metastasis of gastric cancer cells via ZEB1-mediated epithelial- mesenchymal transition.

Authors:  Gan Cao; Dehu Chen; Guiyuan Liu; Yan Pan; Qinghong Liu
Journal:  Onco Targets Ther       Date:  2018-09-21       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.